Amendment
Ecog-acrin ncorp research base - the ecog-acrin cancer research group (EA) is dedicated to decreasing the burden of cancer. EA is a vibrant member of the…
$0
Amendment
$0
Amendment
$0
Amendment
$0
Amendment
Ecog-acrin ncorp research base - the ecog-acrin cancer research group (EA) is dedicated to decreasing the burden of cancer. EA is a vibrant member of the…
$0
Amendment
$564,728
Amendment
$13,043,420
Amendment
$5,087,073
Amendment
$5,087,073
Amendment
$5,087,073
Amendment
$15,000,000
Amendment
$15,000,000
Amendment
$5,154,867
Amendment
Ecog-acrin ncorp research base - tmist - the broad long-term objective is to reduce cancer health disparities in women of color (WOC) through increased…
$5,154,867
Amendment
$5,154,867
Amendment
$322,207
Amendment
$322,207
Amendment
$322,207
Amendment
$322,207
Amendment
$18,919,381
Amendment
$18,919,381
Amendment
$18,919,381
Amendment
$18,919,381
Amendment
$18,919,381
Amendment
$514,608
Amendment
$6,780,545
Amendment
$514,608
Amendment
$6,780,545
Amendment
$514,608
Amendment
-$0
Amendment
-$0
Amendment
-$0
Amendment
-$0
Amendment
-$0
Amendment
$0
Amendment
$0
Amendment
$0
Amendment
$0
Amendment
$0
Amendment
Ecog-acrin ncorp research base - the broad long-term objective is to reduce cancer health disparities in women of color (WOC) through increased participation in…
$945,901
Amendment
$945,901
Amendment
$945,901
Amendment
$945,901
Amendment
$945,901
Amendment
$945,901
Amendment
Ecog-acrin ncorp research base - the broad long-term objective is to reduce cancer health disparities in women of color (WOC) through increased participation in…
The General Hospital CorporationNCORP YR11 Extension - EAY251 Atrium Funding SOW - Clinical Coordinating Center (CCC) For this subcontract, the MGH Clinical Coordinating Center (CCC) will…
$769,390
Brigham & Womens Hospital Inc.NCORP YR11 Extension - EAY251 Atrium Funding BWH, under the leadership of Dr. Paul Ridker, will serve as the Principal Investigator of the Data Coordinating…
Rector & Visitors Of The University Of VirginiaNCORP YR9 Funding - E2906 Subrecipient agrees to perform the BIQSFP proposal including but limited to the Next Generation Sequencing (NGS) Panel DNA…
UG1CA189828 was awarded to Ecog-Acrin Medical Research Foundation, Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2014.
How much is award UG1CA189828 worth?
$310,139,038 has been obligated on UG1CA189828: $302,164,885 in federal funding and $7,974,153 in non-federal funding.